2007 New Frontiers in Cancer Detection & Diagnosis Gordon Conference

描述（由申请人提供）：早期癌症的准确检测对于通过制定癌症特异性干预措施来改善患者护理至关重要，以避免侵袭、转移、传播和随后的晚期疾病。国家癌症研究所癌症预防司建立了早期检测研究网络（EDRN），这是一个多机构联盟，致力于改进在早期阶段检测癌症的方法。EDRN已经发展成为一个具有重大价值和范围的国际研究项目，支持和促进广泛的研究活动，特别是用于准确检测早期癌症的分子生物标志物的发现、开发和验证。拥有尖端技术，多学科专家在EDRN共同努力，以实现改善患者护理的使命。

DESCRIPTION (provided by applicant): The accurate detection of early stage cancer is critical to improve patient care by developing cancer specific interventions to avert invasion metastatic dissemination and subsequent advanced disease. The National Cancer Institute's Division of Cancer Prevention has established the Early Detection Research Network (EDRN), a multi-institutional consortium endeavoring to improve methods for detecting cancer at its earliest stage. The EDRN has developed into an international research program of substantial charge and scope that supports and facilitates a broad spectrum of research activities, particularly the discovery, development and validation of molecular biomarkers for the accurate detection of early stage cancer. Armed with cutting-edge technologies, multidisciplinary experts are working together in the EDRN to fulfill the mission of improving patient care. The purpose of this proposed 2007 Gordon Conference on New Frontiers in Cancer Detection and Diagnosis is to bring together junior and senior physicians and scientists with expertise in basic, translational and clinical oncology, as well as experts in computational biology, biotechnology and informatics in a unique nurturing environment conducive to forging partnerships. Such a setting provides a unique opportunity and venue for intense discussion and evaluation of cancer research, establishing the merit of research priorities, and advancement of the field through newly established collaborations. In an atmosphere focused on uniting biology, oncology and technology, physicians and scientists will work together to develop potential clinical applications of cancer biomarkers to improvement of patient care. To support the overall goals and objectives of the conference, the program is organized in nine scientific plenary sections entitled: Biology of Early Cancer Detection I, Biology of Early Cancer II, Enabling Technologies for Biomarker Discovery, Genomics-Based Diagnostic Biomarkers, Omics as Biomarkers: Glycomics, Lipidomics, Metabolomics, State of Proteomics, Epitomics and Immunomics, Biomarkers at a Crossroads: A Clinical reality Check, and Data Mining Based Biomarker Discovery, together with four poster sessions.